Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (Q1937208)

From MaRDI portal
Revision as of 14:02, 16 December 2024 by Import241208061232 (talk | contribs) (Normalize DOI.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Optimal treatment allocation and study duration for trials with discrete-time survival endpoints
scientific article

    Statements

    Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (English)
    0 references
    0 references
    0 references
    28 February 2013
    0 references
    discrete-time longitudinal data
    0 references
    survival analysis
    0 references
    optimal designs
    0 references
    cost function
    0 references
    allocation ratio
    0 references

    Identifiers